Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-05-2024 | Hydroxychloroquine | Case report

Hydroxychloroquine

Various toxicities following off-label use

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Noori YA, et al. Analysis of hydroxychloroquine adverse events in COVID-19 patients reported throughout Iraqi pharmacovigilance center in VigiBaseTM: A study based on WHO database. F1000 Research : Aug 2022. Available from: URL: 10.12688/f1000research.124441.1 Noori YA, et al. Analysis of hydroxychloroquine adverse events in COVID-19 patients reported throughout Iraqi pharmacovigilance center in VigiBaseTM: A study based on WHO database. F1000 Research : Aug 2022. Available from: URL: 10.12688/f1000research.124441.1
Metadata
Title
Hydroxychloroquine
Various toxicities following off-label use
Publication date
01-05-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58204-y

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Venetoclax

Case report

Multiple drugs

Case report

Dapagliflozin

Case report

Pembrolizumab